
{
  "documentMetadata": {
    "title": "Bacillary Angiomatosis, Peliosis",
    "lastUpdated": "2024-10-16",
    "sourceFile": "syndromes/skin_and_soft_tissues/Bacillary Angiomatosis, Peliosis.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Immunocompromised:"
        },
        {
          "type": "list",
          "items": [
            "HIV-positive patients with AIDS (CD4 count < 100 cells/µL)",
            "Cancer and/or organ transplant patients."
          ]
        },
        {
          "type": "crossReference",
          "referenceData": {
            "text": "For Bartonella infection in immunocompetent patient, see Cat Scratch Disease.",
            "targetType": "internalDocument",
            "targetIdentifier": "Cat Scratch Disease"
          }
        },
        {
          "type": "paragraph",
          "text": "Presentation:"
        },
        {
          "type": "list",
          "items": [
            "Uncomplicated: Fever, skin lesions (often mistaken for Kaposi's Sarcoma) with variety of forms (papules, nodules, pedunculated) but always vascular.",
            "Complicated: Disseminated disease can manifest as bone, mucosal, or central nervous system infection. Can present as an FUO or endocarditis."
          ]
        },
        {
            "type": "paragraph",
            "text": "Bacillary peliosis: cystic vascular lesions in liver (in differential diagnosis of liver abscesses) or spleen containing colonies of bacteria."
        },
        {
          "type": "paragraph",
          "text": "Diagnosis:"
        },
        {
          "type": "list",
          "items": [
            "Elevated antibody titer",
            "Histopathology or PCR of affected tissue / biopsy. Histopathology: use a modified silver stain (such as Warthin-Starry stain) numerous bacilli are typically seen. Tissue Gram staining and acid-fast staining are negative"
          ]
        },
        {
          "type": "crossReference",
          "referenceData": {
            "text": "Brief Review (StatPearls)",
            "targetType": "externalURL",
            "targetIdentifier": "https://www.statpearls.com/ArticleLibrary/viewarticle/291"
          }
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Bartonella henselae",
        "Bartonella quintana"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "appliesTo": {
          "description": "Uncomplicated (not disseminated) infection"
        },
        "components": [
          { "drug": "Doxycycline", "dose": "100 mg", "route": "IV/po", "frequency": "bid", "connector": "or" },
          { "drug": "Erythromycin", "dose": "500 mg", "route": "po", "frequency": "q6h", "connector": "or" },
          { "drug": "Azithromycin", "dose": "500 mg", "route": "po", "frequency": "daily" }
        ],
        "durationDetail": { "fixedDuration": "3 months or more" }
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "appliesTo": {
          "description": "Complicated (Disseminated) infection, e.g., CNS involvement"
        },
        "components": [
          { "drug": "Doxycycline", "dose": "100 mg", "route": "IV/po", "frequency": "bid", "connector": "+" },
          { "drug": "Rifampin", "dose": "300 mg", "route": "po", "frequency": "bid" }
        ],
        "durationDetail": { "fixedDuration": "minimum of 4 months" },
        "notes": "See Comment for relapsing disease and possible chronic suppressive therapy if CD4 count < 200 cells/µL."
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "appliesTo": {
          "description": "Uncomplicated (not disseminated) infection"
        },
        "components": [
          { "drug": "Clarithromycin", "dose": "500 mg", "route": "po", "frequency": "twice daily" }
        ],
        "durationDetail": { "fixedDuration": "3 months or more" },
        "notes": "See Comment regarding relapsing disease."
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "paragraph",
      "text": "Note drugs that should not be used: TMP-SMX, Ciprofloxacin, penicillins, cephalosporins."
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Jarisch-Herxheimer reaction may occur in the first 48 hrs of therapy.",
        "After the initial 3-4 months of therapy, regardless of CD4 count, discontinue therapy and observe the patient for relapse. If no relapse, no need for suppressive therapy.",
        "If the patient relapses, re-institute therapy with Erythromycin or Doxycycline as above. Treat for at least 3 months and then, if CD4 count <200, continue as suppressive therapy. Safe to stop suppression when CD4 count >200 for 6 months.",
        "Guidelines at clinicalinfo.HIV.gov.",
        "Reference: Intl J Antimicrob Agents 44:16, 2014."
      ]
    }
  ]
}
